INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 03, 2007 |
Director
Trans History: 330
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,066 | $9.50 | 77,752 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 11,066 | $20.00 | 66,686 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | $9.50 | 66,886 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $20.01 | 66,686 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,800 | $9.50 | 70,486 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 3,800 | $20.03 | 66,686 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 957 | $9.50 | 67,643 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 957 | $20.05 | 66,686 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | $9.50 | 66,886 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.